Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08ZZX
|
||||
Former ID |
DNC012769
|
||||
Drug Name |
4-(3-Methoxy-phenyl)-isoxazolidine-3,5-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C10H9NO4
|
||||
Canonical SMILES |
COC1=CC=CC(=C1)C2C(=O)NOC2=O
|
||||
InChI |
1S/C10H9NO4/c1-14-7-4-2-3-6(5-7)8-9(12)11-15-10(8)13/h2-5,8H,1H3,(H,11,12)
|
||||
InChIKey |
GTLJNZXLCZDZRN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Methylglyoxal degradation III | ||||
Acetone degradation I (to methylglyoxal) | |||||
KEGG Pathway | Pentose and glucuronate interconversions | ||||
Fructose and mannose metabolism | |||||
Galactose metabolism | |||||
Glycerolipid metabolism | |||||
Metabolic pathways | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
PathWhiz Pathway | Fructose and Mannose Degradation | ||||
Pyruvate Metabolism | |||||
Pterine Biosynthesis | |||||
Glycerolipid Metabolism | |||||
Galactose Metabolism | |||||
WikiPathways | Metapathway biotransformation | ||||
Polyol Pathway | |||||
Metabolism of steroid hormones and vitamin D | |||||
References | |||||
REF 1 | J Med Chem. 1982 Jun;25(6):745-7.Isoxazolidine-3,5-diones as lens aldose reductase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.